News
What Is PT-141? A Simple Guide to the Research Peptide
A plain, factual overview of PT-141 (bremelanotide), a melanocortin receptor agonist research peptide that grew out of Melanotan II research....
Is Semaglutide FDA Approved? Current Status in 2026
A plain-language, Research Use Only compliant explainer on semaglutide's FDA status in 2026: yes, semaglutide is FDA approved as specific...
Semaglutide vs Tirzepatide: How the Research Peptides Compare
A research-use-only comparison of semaglutide, a single GLP-1 receptor agonist, and tirzepatide, a dual GIP and GLP-1 receptor agonist, summarizing...
What Is Semaglutide? A Plain-Language Guide to the Research Peptide
Semaglutide is a GLP-1 receptor agonist peptide; this plain-language guide explains what it is, its Novo Nordisk origin, cited clinical...
Retatrutide Clinical Trials: Where the Research Stands
An overview of the retatrutide clinical trial program - Phase 2, the Phase 3 TRIUMPH trials, and how trial participation...
Retatrutide News: The Latest Research and Trial Updates
A roundup of the latest retatrutide research and clinical trial news, from Phase 2 through the Phase 3 TRIUMPH program.